Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DTech Lab is a biotechnology company specializing in the development and manufacture of advanced diagnostic solutions for infectious diseases, with a primary focus on tropical illnesses. The company is best known for its high-sensitivity point-of-care diagnostic kits, including the D-Tech Dengue NS1 Ag rapid test, which utilizes proprietary immunochromatographic technology to provide early detection of the virus. Headquartered in Thailand, DTech Lab operates as a spin-off from academic research, bridging the gap between laboratory innovation and clinical application. Their product portfolio extends to Zika and Chikungunya diagnostics, aiming to provide affordable and reliable testing in resource-limited settings. The company maintains a strong presence in Southeast Asia and continues to expand its reach through international distribution partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DTech Lab.